458 related articles for article (PubMed ID: 25985809)
1. Daily home opioid use in adults with sickle cell disease: The PiSCES project.
Smith WR; McClish DK; Dahman BA; Levenson JL; Aisiku IP; de A Citero V; Bovbjerg VE; Roberts JD; Penberthy LT; Roseff SD
J Opioid Manag; 2015; 11(3):243-53. PubMed ID: 25985809
[TBL] [Abstract][Full Text] [Related]
2. Depression and anxiety in adults with sickle cell disease: the PiSCES project.
Levenson JL; McClish DK; Dahman BA; Bovbjerg VE; de A Citero V; Penberthy LT; Aisiku IP; Roberts JD; Roseff SD; Smith WR
Psychosom Med; 2008 Feb; 70(2):192-6. PubMed ID: 18158366
[TBL] [Abstract][Full Text] [Related]
3. Gender differences in pain and healthcare utilization for adult sickle cell patients: The PiSCES Project.
McClish DK; Levenson JL; Penberthy LT; Roseff SD; Bovbjerg VE; Roberts JD; Aisiku IP; Smith WR
J Womens Health (Larchmt); 2006 Mar; 15(2):146-54. PubMed ID: 16536678
[TBL] [Abstract][Full Text] [Related]
4. The association between hydroxyurea adherence and opioid utilization among Texas Medicaid enrollees with sickle cell disease.
Kang HA; Barner JC
J Manag Care Spec Pharm; 2020 Nov; 26(11):1412-1422. PubMed ID: 33119448
[No Abstract] [Full Text] [Related]
5. Differences in quality of life between pediatric sickle cell patients who used hydroxyurea and those who did not.
Nwenyi E; Leafman J; Mathieson K; Ezeobah N
Int J Health Care Qual Assur; 2014; 27(6):468-81. PubMed ID: 25115050
[TBL] [Abstract][Full Text] [Related]
6. Daily pain in adults with sickle cell disease-a different perspective.
van Tuijn CF; Sins JW; Fijnvandraat K; Biemond BJ
Am J Hematol; 2017 Feb; 92(2):179-186. PubMed ID: 27880985
[TBL] [Abstract][Full Text] [Related]
7. Characterization of opioid use in sickle cell disease.
Han J; Zhou J; Saraf SL; Gordeuk VR; Calip GS
Pharmacoepidemiol Drug Saf; 2018 May; 27(5):479-486. PubMed ID: 28815799
[TBL] [Abstract][Full Text] [Related]
8. The role of catastrophizing in sickle cell disease--the PiSCES project.
Citero Vde A; Levenson JL; McClish DK; Bovbjerg VE; Cole PL; Dahman BA; Penberthy LT; Aisiku IP; Roseff SD; Smith WR
Pain; 2007 Dec; 133(1-3):39-46. PubMed ID: 17408858
[TBL] [Abstract][Full Text] [Related]
9. Hypogonadism in men with chronic pain linked to the use of long-acting rather than short-acting opioids.
Rubinstein AL; Carpenter DM; Minkoff JR
Clin J Pain; 2013 Oct; 29(10):840-5. PubMed ID: 24384986
[TBL] [Abstract][Full Text] [Related]
10. Age-related prescription medication utilization for the -management of sickle cell disease among Texas Medicaid patients.
Shukla N; Barner JC; Lawson KA; Rascati KL
J Opioid Manag; 2021; 17(4):301-310. PubMed ID: 34533824
[TBL] [Abstract][Full Text] [Related]
11. Hydroxyurea and acute painful crises in sickle cell anemia: effects on hospital length of stay and opioid utilization during hospitalization, outpatient acute care contacts, and at home.
Ballas SK; Bauserman RL; McCarthy WF; Castro OL; Smith WR; Waclawiw MA;
J Pain Symptom Manage; 2010 Dec; 40(6):870-82. PubMed ID: 20864308
[TBL] [Abstract][Full Text] [Related]
12. Comparisons of high versus low emergency department utilizers in sickle cell disease.
Aisiku IP; Smith WR; McClish DK; Levenson JL; Penberthy LT; Roseff SD; Bovbjerg VE; Roberts JD
Ann Emerg Med; 2009 May; 53(5):587-93. PubMed ID: 18926599
[TBL] [Abstract][Full Text] [Related]
13. Sickle cell disease patients with and without extremely high hospital use: pain, opioids, and coping.
Brown SE; Weisberg DF; Balf-Soran G; Sledge WH
J Pain Symptom Manage; 2015 Mar; 49(3):539-47. PubMed ID: 25057985
[TBL] [Abstract][Full Text] [Related]
14. Sickle cell disease--pathophysiology and treatment.
Redding-Lallinger R; Knoll C
Curr Probl Pediatr Adolesc Health Care; 2006; 36(10):346-76. PubMed ID: 17055417
[No Abstract] [Full Text] [Related]
15. 10-year follow-up of chronic non-malignant pain patients: opioid use, health related quality of life and health care utilization.
Jensen MK; Thomsen AB; Højsted J
Eur J Pain; 2006 Jul; 10(5):423-33. PubMed ID: 16054407
[TBL] [Abstract][Full Text] [Related]
16. Opioid management strategy decreases admissions in high-utilizing adults with sickle cell disease.
Mager A; Pelot K; Koch K; Miller L; Hubler C; Ndifor A; Coan C; Leonard C; Field JJ
J Opioid Manag; 2017; 13(3):143-156. PubMed ID: 28829516
[TBL] [Abstract][Full Text] [Related]
17. Patterns of opioid use in sickle cell disease.
Han J; Saraf SL; Zhang X; Gowhari M; Molokie RE; Hassan J; Alhandalous C; Jain S; Younge J; Abbasi T; Machado RF; Gordeuk VR
Am J Hematol; 2016 Nov; 91(11):1102-1106. PubMed ID: 27466799
[TBL] [Abstract][Full Text] [Related]
18. Adult emergency department patients with sickle cell pain crisis: a learning collaborative model to improve analgesic management.
Tanabe P; Artz N; Mark Courtney D; Martinovich Z; Weiss KB; Zvirbulis E; Hafner JW
Acad Emerg Med; 2010 Apr; 17(4):399-407. PubMed ID: 20370779
[TBL] [Abstract][Full Text] [Related]
19. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members.
Yawn BP; Buchanan GR; Afenyi-Annan AN; Ballas SK; Hassell KL; James AH; Jordan L; Lanzkron SM; Lottenberg R; Savage WJ; Tanabe PJ; Ware RE; Murad MH; Goldsmith JC; Ortiz E; Fulwood R; Horton A; John-Sowah J
JAMA; 2014 Sep; 312(10):1033-48. PubMed ID: 25203083
[TBL] [Abstract][Full Text] [Related]
20. What is the case for prescribing long-acting opioids over short-acting opioids for patients with chronic pain? A critical review.
Rauck RL
Pain Pract; 2009; 9(6):468-79. PubMed ID: 19874536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
